Gonzalez-Reiche, Ana S. http://orcid.org/0000-0003-3583-4497
Alshammary, Hala
Schaefer, Sarah
Patel, Gopi
Polanco, Jose
Carreño, Juan Manuel
Amoako, Angela A.
Rooker, Aria
Cognigni, Christian
Floda, Daniel
van de Guchte, Adriana http://orcid.org/0000-0002-0771-3842
Khalil, Zain
Farrugia, Keith
Assad, Nima
Zhang, Jian
Alburquerque, Bremy http://orcid.org/0000-0002-9115-8318
Kleiner, Giulio
Andre, Dalles
Beach, Katherine F.
Bermúdez-González, Maria C.
Cai, Gianna
Lyttle, Neko
Mulder, Lubbertus C. F.
Oostenink, Annika
Salimbangon, Ashley Beathrese T.
Singh, Gagandeep
van Kesteren, Morgan
Monahan, Brian
Mauldin, Jacob
Awawda, Mahmoud
Sominsky, Levy A. http://orcid.org/0000-0001-8084-3187
Gleason, Charles
Srivastava, Komal
Sebra, Robert http://orcid.org/0000-0001-9267-2426
Ramirez, Juan David
Banu, Radhika
Shrestha, Paras
Krammer, Florian http://orcid.org/0000-0003-4121-776X
Paniz-Mondolfi, Alberto http://orcid.org/0000-0003-1259-1736
Sordillo, Emilia Mia http://orcid.org/0000-0001-7787-3051
Simon, Viviana http://orcid.org/0000-0002-6416-5096
van Bakel, Harm http://orcid.org/0000-0002-1376-6916
,
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (75N93021C00014, 75N93019C00051, R21AI169280)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (ULTR004419)
Article History
Received: 7 October 2022
Accepted: 16 May 2023
First Online: 3 June 2023
Competing interests
: The Icahn School of Medicine at Mount Sinai has filed patent applications relating to SARS-CoV-2 serological assays (U.S. Provisional Application Numbers: 62/994,252, 63/018,457, 63/020,503 and 63/024,436) and NDV-based SARS-CoV-2 vaccines (U.S. Provisional Application Number: 63/251,020) which list Florian Krammer as co-inventor. Viviana Simon is also listed on the serological assay patent application as co-inventor. Patent applications were submitted by the Icahn School of Medicine at Mount Sinai. Mount Sinai has spun out a company, Kantaro, to market serological tests for SARS-CoV-2. Florian Krammer has consulted for Merck and Pfizer (before 2020), and is currently consulting for Pfizer, Third Rock Ventures, Seqirus and Avimex. The Krammer laboratory is also collaborating with Pfizer on animal models of SARS-CoV-2. Robert Sebra is currently a paid consultant and stockholder of GeneDx.